Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Immunocore Holdings PLC Sponsored ADR (IMCR) vs Taysha Gene Therapies, Inc. (TSHA)

Immunocore Holdings PLC Sponsored ADR and Taysha Gene Therapies, Inc. are both Biotechnology companies. Immunocore Holdings PLC Sponsored ADR and Taysha Gene Therapies, Inc. are of similar size ($1.6B and $1.6B). Immunocore Holdings PLC Sponsored ADR grew revenue faster over the last twelve months: 21.0% against 19.0%. Taysha Gene Therapies, Inc. has the higher net margin (0.00% vs −4.20%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Immunocore Holdings PLC Sponsored ADR leads on 9 and Taysha Gene Therapies, Inc. on 7.

Valuation

Metric IMCR TSHA Biotechnology median
P/E n/m n/m 7.88
P/S 3.64 146.12 11.47
P/B 3.73 4.45 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 2.62 111.68 10.73
Earnings yield (1.17%) (8.99%) (28.84%)
Free cash flow yield (2.63%) (8.07%) (23.03%)

Profitability

Metric IMCR TSHA Biotechnology median
Gross margin 98.90% 100.00% 65.16%
Operating margin (5.24%) 0.00% 0.00%
Net margin (4.20%) 0.00% 0.00%
Free cash flow margin (9.55%) 0.00% 0.00%
Return on equity (4.47%) (47.05%) (57.72%)
Return on assets (1.64%) (37.23%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMCR TSHA Biotechnology median
Revenue growth (TTM) 20.95% 18.96% 5.64%
EPS growth (last fiscal year) 30.39% 5.56% —
Revenue growth, 5-year CAGR 59.57% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMCR TSHA Biotechnology median
Debt to equity 0.94 0.13 0.00
Current ratio 4.47 17.76 4.73
Net debt to EBITDA 11.19 2.47 0.96

Dividend

Metric IMCR TSHA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric IMCR TSHA Biotechnology median
Market cap 1.61b 1.56b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack